HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Redox state of near infrared spectroscopy-measured cytochrome aa(3) correlates with delayed cerebral energy failure following perinatal hypoxia-ischaemia in the newborn pig.

Abstract
Early detection of delayed cerebral energy failure may be important in the prevention of reperfusion injury of the brain after severe perinatal hypoxia-ischaemia (HI). This study investigated whether monitoring of the redox state of cytochrome aa(3) (Cytaa(3)) with near infrared spectroscopy (NIRS) after severe perinatal asphyxia may allow us to detect early a compromised energy metabolism of the developing brain. We therefore correlated serial Cytaa(3) measurements (to estimate mitochondrial oxygenation) simultaneously with the (31)phosphorous-magnetic resonance spectroscopy ((31)P-MRS)-measured phosphocreatin/inorganic phosphate (PCr/Pi) ratio (to estimate cerebral energy reserve) in newborn piglets before and after severe hypoxia-ischaemia. The animals were treated upon reperfusion with either allopurinol, deferoxamine, or 2-iminobiotin or with a vehicle to reduce post-HI reperfusion injury of the brain. Four sham-operated piglets served as controls. Before HI, the individual Cytaa(3) values ranged between -0.02 and 0.71 micromol/L (mean value: -0.07) relative to baseline. The pattern over post-HI time of the vehicle-treated animals was remarkably different from the other groups in as far Cytaa(3) became more oxidised from 3 h after start of HI onwards (increase of Cytaa(3) as compared with baseline), whereas the other groups showed a significant reduction over time (decrease of Cytaa(3) as compared with baseline: allopurinol and deferoxamine) or hardly any change (2-iminobiotin and sham-operated piglets). Vehicle-treated piglets showed a significant reduction in PCr/Pi at 24 h after start of HI, but the cerebral energy state was preserved in 2-iminobiotin-, allopurinol- and deferoxamine-treated piglets. With severe reduction in PCr/Pi-ratio, major changes in the redox-state of Cytaa(3) also occurred: Cytaa(3) was mostly either in a reduced state (down to -6.45 micromol/L) or in an oxidised state (up to 6.84 micromol/L) at these low PCr/Pi ratios. The positive predictive value (PPV) of Cytaa(3) to predict severe reduction of the PCr/Pi ratio was 42%; the negative PPV was 87%. A similar relation was found for Cytaa(3) with histologically determined loss of neurons.
AuthorsCacha Peeters-Scholte, Evelyn van den Tweel, Floris Groenendaal, Frank van Bel
JournalExperimental brain research (Exp Brain Res) Vol. 156 Issue 1 Pg. 20-6 (May 2004) ISSN: 0014-4819 [Print] Germany
PMID14689136 (Publication Type: Journal Article)
Chemical References
  • Free Radical Scavengers
  • Iron Chelating Agents
  • Neuroprotective Agents
  • Phosphates
  • Phosphocreatine
  • Allopurinol
  • Biotin
  • Electron Transport Complex IV
  • 2-iminobiotin
  • Deferoxamine
Topics
  • Allopurinol (pharmacology)
  • Animals
  • Animals, Newborn
  • Biotin (analogs & derivatives, pharmacology)
  • Brain (drug effects, metabolism, physiopathology)
  • Cell Survival (drug effects)
  • Deferoxamine (pharmacology)
  • Disease Models, Animal
  • Disease Progression
  • Electron Transport Complex IV (metabolism)
  • Energy Metabolism (drug effects)
  • Free Radical Scavengers (pharmacology)
  • Hypoxia-Ischemia, Brain (drug therapy, metabolism, physiopathology)
  • Iron Chelating Agents (pharmacology)
  • Magnetic Resonance Spectroscopy
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (pharmacology)
  • Oxidation-Reduction (drug effects)
  • Phosphates (metabolism)
  • Phosphocreatine (metabolism)
  • Predictive Value of Tests
  • Spectroscopy, Near-Infrared
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: